https://ichgcp.net/it/news/weill-medical-college-of-cornell-university-is-about-to-start-a-phase-2-open-label-single-arm-study-of-selinexor-in-combination-with-clarithromycin-pomalidomide-and-dexamethasone-in-patients-with-relapsed-refractory-multiple-myeloma